ResearchMoz

Spondylitis Global Clinical Trials Review, H1, 2012

Publisher Name » GlobalData
Published Date » 2012-05-21
No. Of Pages » 67


GlobalData's clinical trial report, Spondylitis Global Clinical Trials Review, H1, 2012" provides data on the Spondylitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spondylitis . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spondylitis . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Spondylitis Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Spondylitis , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Spondylitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Top Companies Participating in Spondylitis Therapeutics Clinical Trials 25
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Asklepios Klinik Sankt Augustin GmbH 28
Clinical Trial Overview of Asklepios Klinik Sankt Augustin GmbH 28
Inflexxion, Inc. 29
Clinical Trial Overview of Inflexxion, Inc. 29
Bayer AG 30
Clinical Trial Overview of Bayer AG 30
Celltrion, Inc. 31
Clinical Trial Overview of Celltrion, Inc. 31
Merck & Co., Inc. 32
Clinical Trial Overview of Merck & Co., Inc. 32
AstraZeneca PLC 33
Clinical Trial Overview of AstraZeneca PLC 33
Abbott Laboratories 34
Clinical Trial Overview of Abbott Laboratories 34
Clinical Trial Overview of Top Universities / Institutes / Hospitals 35
Zahedan University of Medical Sciences 35
Clinical Trial Overview of Zahedan University of Medical Sciences 35
Central Council for Research in Homoeopathy 36
Clinical Trial Overview of Central Council for Research in Homoeopathy 36
Singapore General Hospital 37
Clinical Trial Overview of Singapore General Hospital 37
Rehazentrum Bad Eilsen 38
Clinical Trial Overview of Rehazentrum Bad Eilsen 38
Greenwich Hospital 39
Clinical Trial Overview of Greenwich Hospital 39
Sun Yat-sen University 40
Clinical Trial Overview of Sun Yat-sen University 40
Odense University Hospital 41
Clinical Trial Overview of Odense University Hospital 41
University of Wisconsin Madison 42
Clinical Trial Overview of University of Wisconsin Madison 42
Five Key Clinical Profiles 43

Appendix 64
Abbreviations 64
Definitions 64
Research Methodology 65
Secondary Research 65
About GlobalData 66
Contact Us 66
Disclaimer 66
Source 67

List of Tables

 
Spondylitis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Spondylitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Spondylitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Spondylitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
Spondylitis Therapeutics Clinical Trials, Europe, Top Countries, 2012* 11
Spondylitis Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Spondylitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
Spondylitis Therapeutics Clinical Trials, BRIC Countries, 2012* 14
Spondylitis Therapeutics Clinical Trials, G7 Countries, 2012* 15
Spondylitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Spondylitis Therapeutics Clinical Trials, E7 Countries, 2012* 17
Spondylitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Spondylitis Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19
Spondylitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20
Spondylitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Spondylitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22
Spondylitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24
Spondylitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26
Spondylitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asklepios Klinik Sankt Augustin GmbH, 2012* 28
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Inflexxion, Inc., 2012* 29
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 30
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Celltrion, Inc., 2012* 31
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 32
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 33
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 34
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zahedan University of Medical Sciences, 2012* 35
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Council for Research in Homoeopathy, 2012* 36
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Singapore General Hospital, 2012* 37
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rehazentrum Bad Eilsen, 2012* 38
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Greenwich Hospital, 2012* 39
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 40
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2012* 41
Spondylitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 42

List of Figures

List of Figures

Spondylitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Spondylitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Spondylitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Spondylitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10
Spondylitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2012* 11
Spondylitis Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Spondylitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 13
Spondylitis Therapeutics Clinical Trials, BRIC Countries (%), 2012* 14
Spondylitis Therapeutics Clinical Trials, G7 Countries (%), 2012* 15
Spondylitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Spondylitis Therapeutics Clinical Trials, E7 Countries (%), 2012* 17
Spondylitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Spondylitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19
Spondylitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20
Spondylitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Spondylitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 22
Spondylitis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 23
Spondylitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 25
Spondylitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27
GlobalData Methodology 65

Upcoming Reports:

Industrial Protective Clothing Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth and Forecast, 2012 - 2018
By - Transparency Market Research
Industrial protective clothing is utilized mainly for reducing health risks at the workplace. Chemical and biological industries are required to continuously formulate new methodologies and techniques in order to develop new safety measures for employees. Industrial protective clothing comprises of fire retardant clothing, chemical defending garments, clothing for clean rooms, and limited-use general clothing. Growing health concerns and continuously tightening measures for preventing contamination at the workplace are the primary driving factors which are fuelling the...
Prefilled Syringes Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Prefilled syringes are primary injectable drug delivery devices administered by a medical practitioner or a healthcare provider. These syringes are prefilled with drugs with an appropriate and prescribed amount, and so are ready to be used by the patients directly. Currently, there are over 60 types of drug prefilled syringes available in the market and many more are in product pipelines. Rising incidences of chronic diseases requiring regular drug administration and the rising home healthcare market are the two most influential growth drivers for the prefilled syringes...
Monoclonal Antibodies Market - Global Industry Size, Share, Trends, Analysis and Forecast, 2012 - 2018
By - Transparency Market Research
Monoclonal antibodies have brought a paradigm shift in biotechnology and pharmaceutical sectors. Monoclonal antibodies (mAbs) are mono-specific antibodies which comprise of identical immune cells and these immune cells are clones of a single parent cell and are distinguished by their unique property to bind to the same epitope .  Monoclonal antibodies are now used for treatment of a wide array of diseases, especially cancer, autoimmune, and inflammatory diseases. The development of these new molecular agents, successfully directed to specific cellular targets, is...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

                    

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...